Table 1. HPLC-ESI/MS conditions for the analysis of meloxicam, flunixin, and tulathromycin

Meloxicam Flunixin Tulathromycin
HPLC Shiseido performance liquid chromatography
Mobile Phase A: 10 mM Ammonium Formate A: 0.1% Formic acid in D.W
B: Acetonitrile B: 0.1% Formic acid in Acetonitrile
Gradient 60% (A: 0-9 min) → 60-50% (A: 9-12 min) → 50-20% (A: 12-16 min) → 20-60% (A: 16-20 min)
Flow rate 0.3 mL/min
Column Cadenza 5CD-C18(2.1 mm I.D. × 150 mm, 5 μm)

Mass Spectrometry Thermo Finigan TSQ Quantum Discovery Max
Ion mode ESI (Positive)
Capillary temp 350℃
Collision gas Ar
Collision Energy
Energy Precursor ion(m/z) Fragment ion(m/z)

Meloxicam 352 115,141
Flunixin 297 279,264
Flunixin D3 300 282,264
Tulathromycin 577 116,158
Azythromycin 749 83,158